V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212316 | 20167851 | 1.58 | 38.7 | 03 | 2018-06-02 | 2018-09-29 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101717371 |
| 20212321 | 20167852 | 1.83 | 54.8 | Palliative (P) | 2019-03-14 | 2019-03-15 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100321559 |
| 20212328 | 20167853 | 1.65 | 63 | Palliative (P) | 2015-11-08 | 2016-04-02 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101321861 |
| 20212335 | 20167854 | 1.56 | 71.8 | Neo-adjuvant (N) | 2017-06-09 | 2017-06-16 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100702631 |
| 20212341 | 20167855 | 1.65 | 85.9 | Curative (C) | 2020-08-14 | 2020-08-17 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101051931 |
| 20212347 | 20167857 | 1.81 | 87.8 | null | 2017-09-04 | 2017-09-16 | Trastuzumab | 02 | Y | TRASTUZUMAB | 100714254 |
| 20212361 | 20167858 | 1.78 | 83 | Palliative (P) | null | 2021-10-24 | CETUXIMAB | 02 | N | CETUXIMAB | 100049025 |
| 20212371 | 20167859 | 1.63 | 87.8 | null | 2021-11-21 | 2022-01-08 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100310925 |
| 20212381 | 20167860 | 1.52 | 70.3 | Palliative (P) | 2020-05-23 | 2021-03-31 | Cetuximab 14 day | 2 | null | CAPECITABINE + CISPLATIN | 101719806 |
| 20212385 | 20167861 | 1.63 | 95.95 | null | 2016-09-09 | 2016-11-30 | CETUXIMAB | 2 | N | CAPECITABINE + CISPLATIN | 100623997 |
| 20212386 | 20167862 | 1.75 | 46.6 | null | 2017-08-08 | 2018-09-15 | CETUXIMAB | 02 | null | CETUXIMAB | 101207401 |
| 20212393 | 20167863 | 1.73 | 56 | Palliative (P) | 2022-01-03 | 2022-01-08 | Trastuzumab | 02 | N | TRASTUZUMAB | 100060888 |
| 20212394 | 20167864 | 1.75 | 86.2 | Palliative (P) | 2017-09-17 | 2017-10-01 | Trastuzumab | 02 | N | TRASTUZUMAB | 101367110 |
| 20212401 | 20167865 | 1.58 | 92 | null | 2016-09-10 | 2017-01-19 | Trastuzumab | 02 | null | TRASTUZUMAB | 100495119 |
| 20212402 | 20167866 | 1.65 | 78.2 | Palliative (P) | 2019-08-14 | 2019-09-14 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 101772809 |
| 20212407 | 20167867 | 1.66 | 79.8 | Neo-adjuvant (N) | 2016-08-28 | 2018-03-26 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 100718415 |
| 20212416 | 20167868 | 1.52 | 59.5 | null | 2016-07-19 | 2017-06-19 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101804402 |
| 20212421 | 20167869 | 1.93 | 55 | Palliative (P) | 2016-08-31 | 2016-09-10 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 101243648 |
| 20212427 | 20167870 | 1.57 | 106.6 | Palliative (P) | 2018-07-13 | 2019-01-28 | CETUXIMAB | N | N | CETUXIMAB | 101165088 |
| 20212428 | 20167871 | 1.63 | 70.7 | Curative (C) | 2021-05-17 | 2021-05-21 | Capecitabine + Cisplatin | N | Y | CAPECITABINE + CISPLATIN | 101443647 |
| 20212435 | 20167872 | 1.66 | 75.8 | Adjuvant (A) | null | 2018-06-04 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN | 101684398 |
| 20212440 | 20167873 | 1.82 | 54.4 | null | 2020-12-02 | 2020-12-02 | Cetuximab 14 day | 02 | null | CETUXIMAB | 100605056 |
| 20212444 | 20167874 | 1.84 | 52.4 | Palliative (P) | 2017-11-01 | 2017-11-01 | Trastuzumab 21 day loading dose | 02 | null | TRASTUZUMAB | 100919051 |
| 20212447 | 20167875 | 1.71 | 72.9 | null | 2016-06-26 | 2020-12-20 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 100124259 |
| 20212448 | 20167876 | 1.9 | 85.7 | Palliative (P) | 2018-07-14 | 2018-08-23 | Trastuzumab | 02 | N | TRASTUZUMAB | 101317081 |
| 20212449 | 20167877 | 1.77 | 102 | null | 2022-01-29 | 2022-02-05 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101558204 |
| 20212457 | 20167878 | 1.74 | 48.7 | null | 2017-01-07 | 2017-01-28 | Cetuximab 14 day | 02 | N | CETUXIMAB | 101095116 |
| 20212467 | 20167879 | 1.83 | 83.2 | Adjuvant (A) | 2016-02-09 | 2019-09-05 | CETUXIMAB | 02 | null | CETUXIMAB | 101797961 |
| 20212478 | 20167880 | 1.78 | 62.6 | Palliative (P) | 2017-09-14 | 2017-09-21 | CETUXIMAB | 02 | N | CETUXIMAB | 100498306 |
| 20212482 | 20167881 | 1.73 | null | Palliative (P) | 2021-03-28 | 2021-04-14 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101059947 |
| 20212488 | 20167882 | 1.83 | 53.4 | Palliative (P) | 2020-04-11 | 2020-06-08 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100362655 |
| 20212496 | 20167883 | 1.84 | 60.8 | Curative (C) | 2019-06-22 | 2019-08-03 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100875894 |
| 20212515 | 20167884 | 1.75 | 75 | Curative (C) | 2017-08-13 | 2017-08-13 | Cetuximab 14 day | 02 | N | CETUXIMAB | 100394523 |
| 20212516 | 20167885 | 1.57 | 42.8 | Adjuvant (A) | 2020-04-15 | 2020-05-14 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100294510 |
| 20212522 | 20167886 | 1.64 | 63.3 | Adjuvant (A) | 2020-10-11 | 2020-10-28 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100163421 |
| 20212527 | 20167887 | 1.85 | 78 | null | 2019-05-05 | 2019-10-11 | Capecitabine + Cisplatin | N | null | CAPECITABINE + CISPLATIN | 101838385 |
| 20212529 | 20167888 | 1.75 | 74.55 | null | 2021-09-23 | 2021-12-20 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100018527 |
| 20212534 | 20167889 | 1.57 | 100.9 | Palliative (P) | 2018-10-04 | 2018-10-25 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 100870178 |
| 20212538 | 20167890 | 1.65 | 55 | Palliative (P) | 2016-06-08 | 2016-07-03 | CETUXIMAB | 02 | N | TRASTUZUMAB | 101013196 |
| 20212566 | 20167891 | null | null | Neo-adjuvant (N) | null | 2020-07-30 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100773345 |
| 20212567 | 20167892 | 1.7 | 67.25 | null | null | 2019-08-01 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100523402 |
| 20212574 | 20167893 | 1.72 | 105.9 | Curative (C) | 2022-02-14 | 2022-03-08 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101140772 |
| 20212580 | 20167894 | 1.46 | 65 | Palliative (P) | 2020-04-10 | 2020-04-24 | Irinotecan + Modified De Gramont | 02 | N | IRINOTECAN + MDG | 101602604 |
| 20212584 | 20167895 | 1.67 | 86 | Palliative (P) | null | 2022-01-01 | Irinotecan | 02 | N | IRINOTECAN | 101342937 |
| 20212590 | 20167896 | null | 59 | null | 2020-12-21 | 2021-02-09 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 01 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101368052 |
| 20212597 | 20167897 | 1.72 | 68.05 | null | 2018-12-28 | 2019-06-16 | Irinotecan | 02 | N | IRINOTECAN | 100685744 |
| 20212608 | 20167898 | 1.67 | 43.95 | Curative (C) | 2019-10-04 | 2019-10-04 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | null | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100879495 |
| 20212610 | 20167899 | 1.78 | 116.9 | null | 2017-03-25 | 2017-04-05 | Irinotecan | 02 | null | IRINOTECAN | 101534457 |
| 20212631 | 20167900 | 1.53 | 80 | Palliative (P) | 2018-11-12 | 2020-01-26 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | IRINOTECAN | 101064080 |
| 20212633 | 20167901 | null | 63.7 | Palliative (P) | null | 2018-02-18 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | N | N | IRINOTECAN + MDG | 101366201 |